AQST: Aquestive Therapeutics, Inc. Stock

by  •  • Comments Off on AQST: Aquestive Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 314.08
Enterprise Value ($M) 247.50
Book Value ($M) -36.30
Book Value / Share -0.40
Price / Book -8.65
NCAV ($M) -52.45
NCAV / Share -0.58
Price / NCAV -5.99

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.50
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.85
Current Ratio 6.28

Balance Sheet (mrq) ($M)
Current Assets 113.38
Assets 129.52
Liabilities 165.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 50.58
Operating Income -15.10
Net Income -7.87
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.38
Cash from Investing -0.99
Cash from Financing 3.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13G Venrock Healthcare Capital Partners III, L.P. 6.50
02-14 13G Armistice Capital, Llc 5.88

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 619,381 2,692,306 23.01
2024-07-25 559,685 1,792,763 31.22
2024-07-24 598,347 1,820,782 32.86
2024-07-23 324,236 1,325,439 24.46
2024-07-22 325,211 1,242,560 26.17

(click for more detail)

Similar Companies
ANIP – ANI Pharmaceuticals, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc.


Financial data and stock pages provided by
Fintel.io